tenapanor

 

Topic mentions per year

Topic mentions per year

2014-2018
02420142018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Hyperphosphatemia is common among patients with CKD stage 5D and is associated with morbidity and mortality. Current guidelines… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2017
2017
Tenapanor (RDX5791, AZD1722), a first-in-class small molecule with minimal systemic availability, is an inhibitor of the sodium… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2017
2017
Objectives:Tenapanor is a first-in-class, small-molecule inhibitor of the gastrointestinal sodium/hydrogen exchanger NHE3. This… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2017
2017
AIM Tenapanor (RDX5791/AZD1722), an inhibitor of gastrointestinal Na+ /H+ exchanger NHE3, is being evaluated for the treatment of… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2017
2017
Tenapanor (RDX5791, AZD1722) is an inhibitor of sodium/hydrogen exchanger isoform 3 in development for the treatment of… (More)
Is this relevant?
2016
2016
BACKGROUND AND OBJECTIVES Interdialytic weight gain in patients on hemodialysis is associated with adverse cardiovascular… (More)
Is this relevant?
2016
2016
Tenapanor (RDX5791, AZD1722), a small molecule with minimal systemic availability, is an inhibitor of the sodium/hydrogen… (More)
Is this relevant?
2015
2015
In CKD, phosphate retention arising from diminished GFR is a key early step in a pathologic cascade leading to hyperthyroidism… (More)
Is this relevant?
Review
2015
Review
2015
INTRODUCTION Constipation-predominant irritable bowel syndrome (IBS-C) is a common functional gastrointestinal (GI) disorder… (More)
  • figure 1
Is this relevant?
2014
2014
The management of sodium intake is clinically important in many disease states including heart failure, kidney disease, and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?